Federal Reserve‘s “endless QE” cheers markets
America's Federal Reserve has slashed interest rates and launched unprecedented bond-buying programmes that stretched its mandate to its limits. More could be in store next year.

The post-election stockmarket is a “Labrador”, writes Ben Wright in The Daily Telegraph. Like the dog breed, it is proving “monomaniacally cheerful irrespective of circumstances”. Global markets had perked up in the days before the US election; polls suggested a Democratic blue wave would open the way for a $2.2trn stimulus package.
Yet when it became clear that Florida and Texas would not be painted blue, markets didn’t retreat. Instead, they decided that a Biden White House combined with a Republican Senate was what they had wanted all along. As the world waited for a final election call, the S&P 500 gained 7.3%, its best weekly performance since April.
A Biden White House with a Republican Senate is good news for US stocks, Andy LaPerriere of Cornerstone Macro told Barron’s. The Senate will block Democrat tax hikes on business, while a Biden administration should bring greater calm on the trade war front. The idea that divided government is good for equities is something of a Wall Street cliché. Yet there is little evidence for the idea that it is best when opposing parties are in Congress and the White House, says Paul Vigna in the Wall Street Journal. Since 1928 “there has been virtually no difference in the annual return of the S&P 500” between years with united and divided governments. If fact, stocks “slightly outperformed” when the executive and the legislature were in the same hands.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The almighty Fed
British stocks managed an even more impressively Panglossian feat, notes Philip Aldrick in The Times. The FTSE 100 gained more than 6% last week despite the small matter of England returning to a nationwide lockdown. In a world where fresh quantitative easing (QE)is always available, “bad news is no longer bad news… because policymakers won’t allow it”. In 2008 the banks were “too big to fail”, now that is true of the entire market. Central bankers won’t admit it openly, but there is a “price floor for assets… Call it market welfare for financiers”. The Federal Reserve last week agreed to keep interest rates at between 0% and 0.25% and continue its monthly purchases of $120bn-worth of bonds and mortgage-backed securities with printed money. The Fed’s balance sheet has soared from $4.1trn before the pandemic began to $7.1trn today, equivalent to 34% of 2019 US GDP.
Federal Reserve chairman Jerome Powell has done more than any politician to stabilise the markets this year, says Nicholas Jasinski in Barron’s. In the spring he slashed interest rates and launched unprecedented bond-buying programmes that stretched the Fed’s mandate to its limits. More could be in store next year. For investors, it is Jerome Powell, not Joe Biden, who is the man to watch in 2021.
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Alex is an investment writer who has been contributing to MoneyWeek since 2015. He has been the magazine’s markets editor since 2019.
Alex has a passion for demystifying the often arcane world of finance for a general readership. While financial media tends to focus compulsively on the latest trend, the best opportunities can lie forgotten elsewhere.
He is especially interested in European equities – where his fluent French helps him to cover the continent’s largest bourse – and emerging markets, where his experience living in Beijing, and conversational Chinese, prove useful.
Hailing from Leeds, he studied Philosophy, Politics and Economics at the University of Oxford. He also holds a Master of Public Health from the University of Manchester.
-
Ben Cohen: The Ben & Jerry’s co-founder who wants to break away from Unilever
Ben Cohen of Ben & Jerry’s ice cream is seeking to break away from Unilever, the conglomerate he sold out to in 2000. It’s a battle for the soul of the brand synonymous with corporate do-gooding.
By Jane Lewis
-
Trump wants to colonise Mars – will it happen?
Donald Trump wants to plant the US flag on Mars. Could humans really live there?
By Simon Wilson
-
Klarna postpones US IPO as Trump's tariffs rattle markets
Buy-now-pay-later lender Klarna has postponed its US initial public offering owing to the market turbulence. It is not alone, says Matthew Partridge
By Dr Matthew Partridge
-
Falling revenues and mounting debt spell trouble for Jumia Technologies
Struggling African e-commerce platform Jumia Technologies looks headed for the exit, says Dr Matthew Partridge.
By Dr Matthew Partridge
-
Next reports £1 billion in annual profits for the first time – what's next for the retailer?
Clothing retailer Next has become only the fourth member of its sector to surpass £1 billion in annual profits. What does this mean for the company's future?
By Dr Matthew Partridge
-
Best of British bargains: cash in on undervalued companies in the UK stock market
Opinion Michael Field, Chief Equity Market Strategist, EMEA, Morningstar, selects three attractive UK stocks where he'd put his money
By Michael Field
-
Building firm Keller presents low debt and ample scope for growth
Geotechnical contractor Keller, which supports vital global infrastructure, boasts rising profits and a cheap valuation
By Dr Mike Tubbs
-
PZ Cussons share price down 75% in last decade – why it's one to watch
Opinion Once-strong consumer-goods business PZ Cussons is out of favour with the market. That spells opportunity for investors, says Jamie Ward
By Jamie Ward
-
Cash in on the biotech sector with specialist trust BioPharma
Opinion BioPharma has an attractive niche in lending to asset-rich biotechnology companies
By Rupert Hargreaves
-
India's stock market decline wipes out $1.3 trillion in market value – can investors stay optimistic?
More than $1 trillion has been wiped off from India's stock market after investors turn to China. Has the emerging-market darling hit rock bottom?
By Alex Rankine